ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 68 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $65,133 | -23.4% | 122,892 | +5.2% | 0.01% | -31.6% |
| Q3 2022 | $85,000 | -66.8% | 116,780 | -47.9% | 0.02% | -62.7% |
| Q2 2022 | $256,000 | -41.6% | 224,221 | +5.0% | 0.05% | -28.2% |
| Q1 2022 | $438,000 | -25.3% | 213,469 | +4.9% | 0.07% | -21.1% |
| Q4 2021 | $586,000 | -25.3% | 203,509 | +10.0% | 0.09% | -25.0% |
| Q3 2021 | $784,000 | -84.6% | 184,935 | -80.8% | 0.12% | -84.6% |
| Q2 2021 | $5,092,000 | +51.8% | 962,632 | +33.4% | 0.78% | +31.8% |
| Q1 2021 | $3,355,000 | +1309.7% | 721,587 | +899.9% | 0.59% | +974.5% |
| Q4 2020 | $238,000 | +128.8% | 72,169 | +128.7% | 0.06% | +77.4% |
| Q3 2020 | $104,000 | +153.7% | 31,552 | +156.8% | 0.03% | +121.4% |
| Q2 2020 | $41,000 | – | 12,286 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |